Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

226 Views

Poster Session: Antimicrobial Novel Agents

1699 - Efficacy and Safety by BMI Category and Gender in Contezolid and Contezolid Acefosamil Phase 2 and Phase 3 Skin Infection Clinical Trials

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

EF

Edward Fang, MD

Chief Medical Officer
MicuRx Pharmaceuticals Inc
San Carlos, California, United States

Co-Author(s)

HY

Huahui Yang, MS

MicuRx Pharmaceuticals Inc
Shanghai, Shanghai, China
HY

Hong Yuan, MS

MicuRx Pharmaceuticals Inc, Foster City, CA, USA
shanghai, Shanghai, China